Food Safety & Nutrition

Reference 8 - A Theoretical Basis for a Biopharmaceutic Drug Classification

Reference 9 - Population pharmacokinetics of dabrafenib

Reference 10 - Dabrafenib in patients with melanoma

Reference 11 - Assessment of the drug interaction potential

Reference 12 - Clinical Pharmacology Review of NDA 202806

Reference 13 - M9 Biopharmaceutics Classification System-Based Biowaivers

Reference 14 - Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage

Reference 15 - Evaluation of the effect of dabrafenib and metabolites on QTc interval in patients

Reference 16 - Evaluating the Role of Solubility in Oral Absorption of

Reference 17 - In Silico Modelling Approach for the Evaluation of

Reference 18 - Bioequivalence Studies for Generic Drug Development

Reference 19 - Improving the Dissolution Rate of the Anticancer Drug Dabrafenib